2018 Competition Prospecting 
CloserIQ
DECEMBER 26, 2018
2018 has been an amazing year for all of us at CloserIQ , and we can’t believe we’re just a few days away from welcoming another one. Here are 20+ of our favorite sales blogs from 2018. In an industry full of numbers and data, a healthy competition can be the key to get your sales team performing.
Sales Talent
JULY 16, 2020
This flood of competition means that employers have choices, and job seekers need to sharpen their interviewing skills. Don’t leave the hiring manager wondering if you also fail to follow up with customers and prospects. In 2018, I took over a new territory for my current employer. in February 2020. Poor writing skills.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CloserIQ
JANUARY 11, 2019
“Even though natural-born salespeople are very competitive by their very nature, it’s good to have competition for motivation. Additionally, it’s good for each rep to have their own VA for research and prospecting.”. “In the US, more VC-backed companies went public during 2018 than had in a number of years.
Pharmaceutical Technology
JANUARY 22, 2023
In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases. Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry.
Contrarian Sales Techniques
FEBRUARY 1, 2023
By focusing on the benefits, you are more likely to make a strong emotional connection with your prospects, which can lead to a sale. This is what sets your product apart from the competition and gives your customers a reason to choose your product over others. have increased by 2% from 2018 to 2019, reaching over $18 billion in 2019.
Pharmaceutical Technology
DECEMBER 4, 2022
Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Humira biosimilars became available in the EU in October 2018. There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January.
Pharmaceutical Technology
JANUARY 6, 2023
Last week, Novartis announced plans to pay $245 million to end a pay-for-delay legal battle that started in 2018. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.
Expert insights. Personalized for you.
79 
Let's personalize your content